Latest Articles

As tighter regulations mandate more rigorous testing, cannabis labs in California must plan and adapt to keep up with the huge influx of samples.

The problem is that much of what determines happiness is outside of our control.

From decluttering waiting rooms to assisting diagnostics, AI is changing the face of healthcare. In this article, Yaroslav Kuflinski looks over some of the software that is moving medicine forward.

CPC extracts products with nearly 100 percent purity at a 95 percent recovery rate and as such could be used to research, develop and produce cannabis-derived medicines.

Nearly half of adults with autism will experience clinical depression in their lifetime, according to new research.

Here's what you need to know.

"We don’t consciously choose our thoughts or our feelings – we become aware of them."

When a company strives to make an excellent product, they start with the highest quality materials. Cell therapy is unique in that the building blocks for the “product” are living human cells; since each donor is unique, variability is inevitable. Choosing optimal apheresis instrumentation and collection methods is one of the most important steps in ensuring high-quality starting material.

The changes concern the reclassification of cannabis to make it a schedule 2 drug, allowing it to be prescribed by medical professionals and possessed lawfully by anybody with a valid medical prescription.

Two weeks ago, the Nuffield Council on Bioethics released a seminal report on the social and ethical issues of heritable genome editing. In an article written exclusively for Technology Networks, Hugh Whittall, Director of the Council, looks in-depth at the conclusions and implications of the Council's report.